title: Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011).
authors.forename: Annalisa
authors.initials: A
authors.lastname: Marcuzzi
authors.forename: Valentina
authors.initials: V
authors.lastname: Zanin
authors.forename: Sergio
authors.initials: S
authors.lastname: Crovella
authors.forename: Alessandra
authors.initials: A
authors.lastname: Pontillo
mesh_terms: D050071:Bone Density Conservation Agents / Q000009:adverse effects; D004164:Diphosphonates / Q000009:adverse effects*; D004224:Diterpenes / Q000627:therapeutic use*; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced / Q000188:drug therapy*; D010020:Osteonecrosis / Q000139:chemically induced / Q000188:drug therapy*
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D004224:Diterpenes; C017338:geranylgeraniol